Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 24, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals, Inc. Announces Third Quarter 2014 Earnings Call

BETHESDA, Md., Oct. 24, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will host its third quarter 2014...
October 23, 2014 16:02 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Solidifies Leadership Team With Additions of CSO and Heads of Business Development, Regulatory Affairs

BETHESDA, Md., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced three executive appointments that expand and...
October 21, 2014 18:00 ET | Source: Sucampo Pharmaceuticals Inc

Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)

BETHESDA, Md., October 21, 2014 and OSAKA, Japan, October 22, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, and Takeda...
October 14, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Extension of AMITIZA(R) (lubiprostone) License and Collaboration Agreement With Takeda

BETHESDA, Md., Oct. 14, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it signed on October 9, 2014 an...
October 13, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Clinical Data for AMITIZA(R) Lubiprostone to be Presented at the American College of Gastroenterology 2014 Annual Scientific Meeting

BETHESDA, Md., Oct. 13, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for AMITIZA®...
October 09, 2014 16:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Settlement Agreement That Resolves Patent Litigation in U.S. Related to AMITIZA

BETHESDA, Md., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo, R-Tech Ueno, Ltd. (RTU), Takeda...
October 06, 2014 16:02 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Departure of Chief Financial Officer

BETHESDA, Md., Oct. 6, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Cary J. Claiborne, Chief Financial...
September 29, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo and Takeda Launch Direct-to-Consumer Advertising Campaign for AMITIZA(R) (lubiprostone) for Chronic Idiopathic Constipation

BETHESDA, Md., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP) and its development and commercialization partner, Takeda Pharmaceuticals (Takeda), today...
August 21, 2014 16:30 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces New Exclusive Global Manufacturing and Supply Agreement for Lubiprostone

BETHESDA, Md., Aug. 21, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that its subsidiary, Sucampo AG, has signed...
August 05, 2014 06:15 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Reports Second Quarter 2014 Financial Results and Corporate Update

Positive Net Income Driven by Strong Revenue Growth in Product Royalty and Product Sales CEO Peter Greenleaf to Discuss Results of Sucampo's Strategic Review Company Raises Full Year 2014...